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Abstract
Purpose To evaluate the role of urbanization as an effect
modifier for the association between specific chronic con-
ditions and number of conditions with health-related
quality of life (QOL).
Methods We analyzed cross-sectional data from the CRO-
NICAS Cohort Study conducted in Lima (highly urbanized),
Tumbes (semi-urban), as well as rural and urban sites in
Puno. Exposures of interest were chronic bronchitis,
depressive mood, hypertension, type 2 diabetes, and a
composite variable aggregating the number of chronic con-
ditions (the four exposures plus heart disease and stroke).
QOL outcomes were assessed with EuroQol’s EQ-5D visual
analogue scale (EQ-VAS). We fitted linear regressions with
robust variance to evaluate the associations of interest. Study
site was assessed as a potential effect modifier using the
likelihood-ratio (LR) test.
Results We evaluated data on 2433 subjects: 51.3% were
female, mean age was 57.2 years. Study site was found to be
an effect modifier only for the association between depres-
sive mood and EQ-VAS score (LR test p\ 0.001). Com-
pared to those without depressive mood, participants with
depressive mood scored -13.7 points on the EQ-VAS in
Lima, -7.9 in urban Puno, -11.0 in semi-urban Tumbes,
and -2.7 in rural Puno. Study site was not found to be an
effect modifier for the association between the number of
chronic conditions and EQ-VAS (LR test p = 0.64).
Conclusion The impact of depressive mood on EQ-VAS
was larger in urban than in rural sites, while site was not an
effect modifier for the remaining associations.
Keywords Health-related quality of life  Multiple chronic
conditions  Burden of disease  Depressive mood
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Introduction
Health-related quality of life (QOL) is defined as ‘‘an indi-
vidual’s or a group’s perceived physical and mental health
over time’’ [1]. QOL is worse in patients with chronic non-
communicable conditions, who may face a multitude of
clinical, psychosocial, and economic challenges [2–4].
Consequently, poorer QOL scores are observed with each
additional chronic condition [4–11]. Although not all
chronic conditions affect QOL in the same magnitude, the
list of conditions notably affecting QOL includes chronic
pain disorders and psychiatric conditions [4, 12, 13].
The impact of chronic conditions on QOL could be
altered by urbanization level. In rural areas, barriers to
healthcare access may challenge clinical follow-up and
disease management [14–16], translating to lower QOL
scores than those in urban sites with more access to med-
ical care. On the other hand, individuals in rural areas do
have higher indices of social support [17] which could
promote better QOL and thus balance the effect of lower
access to healthcare services in these areas. In addition,
differences in culture and customs between areas of dif-
ferent urbanization levels could further modify how
chronic conditions impact health-related QOL.
Understanding how chronic conditions affect QOL,
particularly across different cultural contexts and regions
might help to evaluate the relative impact of chronic con-
ditions, prioritize conditions within limited-resources sites,
and design site-specific interventions to improve QOL
across different contexts [18]. To date, the majority of
studies assessing the association between chronic condi-
tions and QOL have been conducted in urban areas, and we
could not find studies exploring how urbanization modifies
the chronic condition-QOL association.
Therefore, this study uses data from four sites in Peru
with varying degrees of urbanization, with the objective to
evaluate the role of urbanization as an effect modifier for
the association between specific chronic conditions and
number of conditions with health-related QOL.
Methods
Study design and sites
This is a secondary analysis using data derived from the
CRONICAS Cohort Study, conducted in four diverse sites
in Peru: (1) Las Pampas de San Juan de Miraflores, a highly
urbanized site in Lima, Peru’s capital, located at sea level
with *15,000 people/km2. (2) Urban Puno, a city with
approximately 150,000 inhabitants located at 3825 m
above sea level in the Peruvian Andes. (3) Semi-urban
costal site in Tumbes, located at sea level in north Peru
near the Equator, composed of a group of communities
with about 20,000 people spread over 80 km2. (4) Rural
Puno, composed of a group of rural villages surrounding
urban Puno [19].
Participants
At baseline in 2010, the CRONICAS Cohort Study
recruited individuals with a minimum age of 35 years who
were full-time residents of the selected population sites. A
single random selection of subjects was performed at each
site, stratified by sex and age, using the most updated
census data available. Only one participant per household
was enrolled, as detailed elsewhere [19]. The first and
second follow-up assessments were completed, on average,
15 and 30 months after baseline. For the present study, we
only included participants who completed the second fol-
low-up as the outcome of interest was evaluated in this
assessment, and included those who had provided all the
variables of interest.
Procedures
A detailed questionnaire was administrated by trained
fieldworkers including socio-demographic characteristics,
self-report of chronic conditions, and the Center for Epi-
demiological Studies Depression Scale [20].
Systolic and diastolic blood pressures were measured
three times using an automatic monitor OMRON HEM-780
after 5 min of resting period, and the mean of the last two
measurements were used. In addition, fasting blood glucose
samples were obtained and processed using an enzymatic
colorimetric method (GOD-PAP; Modular P-E/Roche-
Cobas, Grenzach-Whylen, Germany) and analyzed at an
off-site facility in Lima, following standard laboratory
techniques and quality control procedures as detailed
elsewhere [19].
Outcome: quality of life
QOL was assessed with the EuroQol-5D (EQ-5D) ques-
tionnaire, which includes the visual analogue scale (EQ-
VAS) and a 5-dimensions questionnaire. We used EQ-VAS
scores as our main outcome. It assesses perceived QOL by
asking participants to rank their current state of wellness
from zero, worst imaginable health, to 100, best imaginable
health [21, 22].
The 5-dimension questionnaire was our secondary out-
come. It evaluates QOL across five health status dimen-
sions: mobility, self-care, usual activities, pain/discomfort,
and anxiety/depression. Within each dimension, severity is
evaluated with three categories: no problems, some prob-
lems, and extreme problems [21, 22]. For our analysis,
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each dimension was dichotomized as ‘‘no problems’’ and
‘‘some or extreme problems.’’
We decided not to use the EQ-5D tariffs validated for
other Latin American countries because these have not
been validated for rural settings where EQ-5D items could
have a different impact.
Exposure: chronic conditions
We included the most prevalent chronic conditions col-
lected in the CRONICAS Cohort Study. Exposures of
interest were chronic bronchitis, depressive mood, hyper-
tension (HTN), type 2 diabetes (T2D), and, separately, a
composite variable aggregating the number of chronic
conditions (the four exposures plus heart disease and
stroke). Heart disease and stroke were uncommon in rural
Puno, so were not included as single exposures in the
analyses.
The rationale for the selection of particular chronic
conditions was the availability of objective measurements,
validated instruments, as well as conditions with less recall
bias. The operational definition of each chronic condition
was based in previous references, as detailed in Table 1.
Effect modifier: study site
Study site, which refers to the site where participants lived,
was categorized according to gradient of urbanization as
follows: highly urban Lima, urban Puno, semi-urban
Tumbes, and rural Puno.
Other variables
Other variables included in the analyses were sex, age
(categorized as\45, 45–54, 55–64, and C65 years), edu-
cational level (primary or less: 0–6 years, secondary:
7–11 years, and superior: C12 years), and wealth index (in
tertiles). The wealth index was constructed based on
household income, assets, and household facilities as sug-
gested elsewhere, with higher scores indicating greater
levels of wealth [26].
Statistical analyses
For descriptive analysis, means, standard deviations
(±SD), absolute and relative frequencies were used. Chi
square and ANOVA tests were used to compare the four
sites with respect to sex, age, educational level, wealth
index, number of chronic conditions, specific chronic
conditions, EQ-VAS, and EQ-5D dimensions.
We generated linear regression models with robust
variance to calculate coefficients (b) and their 95% confi-
dence intervals (95% CI), to evaluate the association
between five exposures: HTN, chronic bronchitis, depres-
sive mood, T2D, and number of chronic conditions; and
EQ-VAS scores as a numeric outcome. These associations
were calculated for the overall population, and for each
study site. To answer our research question, study site was
assessed as a potential effect modifier using the likelihood-
ratio (LR) test.
For our secondary analyses, we generated Poisson
regression models with robust variance to calculate
prevalence ratios (PR) and 95% CI to evaluate the asso-
ciation between number of chronic conditions and each of
the five EQ-5D dimensions for each of the study sites. Both
linear and Poisson models were adjusted for sex, age,
educational level, and wealth index.
Ethics
Due to high illiteracy rates, especially in rural areas, all
participants provided verbal informed consent. The study
was approved by the Institutional Review Boards at
Universidad Peruana Cayetano Heredia and A.B. PRISMA,
in Lima, Peru, and at the Johns Hopkins Bloomberg School
of Public Health in Baltimore, USA.
Results
Population characteristics
At baseline, 3601 participants were recruited. Of these, 38
died and 865 were lost during follow-up; thus, only 2698
(74.6%) participants were included in the current study.
We further excluded 265 participants with incomplete
chronic disease and/or QOL information. Therefore, our
current analysis includes data from 2433 participants
(67.6% of the original sample enrolled). Participants
included in the analysis were more likely to be from Lima
and Tumbes, be younger, have a secondary-school educa-
tion, and be from the highest wealth index, compared to
those not included (Supplementary Table 1).
Of the 2433 participants included, 891 (36.6%) were
from Lima, 357 (14.7%) from urban Puno, 890 (36.6%)
from Tumbes, and 295 (12.1%) from rural Puno. Mean age
was 57.2 (SD ± 12.3) years, and 1248 (51.3%) were
female (Table 2).
In terms of single chronic conditions, 573 participants
(23.6%) had HTN, 309 (12.7%) had chronic bronchitis, 309
(12.7%) had depressive mood, 254 (10.4%) had T2D, 131
(5.4%) had heart disease, and 20 (0.8%) had a history of
stroke. Chronic bronchitis and depressive mood were more
prevalent in rural Puno. When chronic conditions were
aggregated, 1152 (47.3%) participants had C1 chronic
condition. The number of chronic conditions and
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prevalence of individual chronic conditions varied across
sites, except for stroke. Mean EQ-VAS score was highest
in Lima, and lowest in rural Puno. The prevalence of
having some or extreme problems in most of the EQ-5D
dimensions was lower in Tumbes and higher in rural Puno
(Table 2).
Association between chronic conditions and EQ-
VAS score
When evaluating the relationship between specific chronic
conditions and EQ-VAS score (Table 3), we found that
participants with depressive mood and chronic bronchitis
had significantly lower EQ-VAS scores than those without
these conditions, while EQ-VAS scores in participants with
HTN and T2D were not different compared with those
without these conditions.
Study site was an effect modifier of the association
between having depressive mood and EQ-VAS score (LR
test p\ 0.001), but it was not found to be an effect mod-
ifier for the association between EQ-VAS score and having
HTN, chronic bronchitis, and T2D. Therefore, compared to
those without depressive mood, participants with depres-
sive mood scored -13.7 points on the EQ-VAS in Lima,
-7.9 in urban Puno, -11.0 in semi-urban Tumbes, and
-2.7 in rural Puno.
Across all sites, EQ-VAS score decreased with each
additional chronic condition (Fig. 1). In the adjusted linear
regression, EQ-VAS score was 3.4 points lower for each
additional chronic condition. Study site was not found to be
an effect modifier in this association (LR test p = 0.64)
(Table 3).
Association between number of chronic conditions
and EQ-5D dimensions
In multivariable models, we found that the number of
chronic conditions was associated with all EQ-5D dimen-
sions in the sample as a whole. The highest PR was for
‘‘self-care’’ (PR = 1.98, 95% CI 1.57–2.49), followed by
‘‘anxiety/depression’’ (PR = 1.67, 95% CI 1.53–1.81).
Study site was not an effect modifier for these associations
(Table 4).
Discussion
Main findings
Depressive mood and chronic bronchitis, but not HTN nor
T2D, were associated with lower EQ-VAS scores. Site was
not an effect modifier for the association between EQ-VAS
score and having HTN, chronic bronchitis, and T2D.
However, site was an effect modifier of the association
between EQ-VAS and depressive mood: the EQ-VAS
score was lower in people with depressive mood than in
those without depressive mood, but this difference was
larger in Lima than in rural Puno with a clear pattern of a
gradient in the magnitudes of difference in EQ-VAS scores
observed across the range of urbanization profiles.
Regarding the number of chronic conditions, it was
inversely associated with EQ-VAS scores. The association
between number of chronic conditions and EQ-VAS scores
was similar across all study sites.
Chronic conditions and EQ-VAS score
Depressive mood was the chronic condition that seemed to
have the larger impact in QOL, similar to studies in Finland
[8], Canada [11], Spain [27], and the United States [28].
However, since these studies were also cross-sectional, it is
possible that, at least in some cases, depressive mood could
be the cause rather than the consequence of low QOL.
Thus, longitudinal approaches are needed to identify the
real impact of depressive mood in QOL.
Chronic bronchitis also had a high impact on QOL, as
found in studies that assessed chronic pulmonary condi-
tions (chronic bronchitis, asthma, COPD) [7, 29, 30],
Table 1 Definitions of chronic conditions
Chronic condition Definition
Hypertension Any of the following: systolic blood pressure (SBP) C140 mmHg, or diastolic blood pressure (DBP) C90 mmHg, or
self-report of physician diagnosis and current use of antihypertensive drugs; according to the seventh report of the Joint
National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [23]
Chronic bronchitis Presence of phlegm production on most days for at least 3 months a year, in the last 12 months, similar to previous
studies [24]
Depressive mood A score of C23 in the Spanish-validated version of the Center for Epidemiological Studies Depression Scale [20]
Type 2 diabetes Any of the following conditions: fasting blood glucose C126 mg/dL, or self-report of physician diagnosis and current use
of diabetes medication; according to the World Health Organization definitions [25]
Heart disease Self-report physician diagnosis of heart failure or previous myocardial infarction
Stroke Self-report of previous stroke, diagnosed by a physician
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which is attributed to the impact of chronic cough, short-
ness of breath, and phlegm production [7, 31–34]. This
suggests that chronic bronchitis should be prioritized in
primary care programs in our sites.
EQ-VAS score in persons with T2D was on average 1.3
points lower than in those without T2D. Conversely, in a
population study in Korea, EQ-VAS score was 4.6 points
lower in persons who self-reported T2D than those who did
not [35]. This variation may be due to our inclusion of not
only self-reported T2D cases, but also of those with
abnormal point-of-care fasting blood glucose. As expected,
the very nature of having T2D or hypertension, be it a short
duration with the condition or having them without com-
plications, could explain the little impact of these condi-
tions on QOL found in our study [36, 37]. To evaluate this
hypothesis, we made a post hoc linear regression in our
population, and found that those receiving a prescription
for T2D medications (i.e., those with a T2D diagnosis)
scored 2.6 points lower on the EQ-VAS than those not on
hypoglycemic agents (p = 0.10). This suggests that QOL
was diminished among participants who were aware of
their diagnosis, although other variables such as aware of
Table 2 Descriptive characteristics of the population according to site
Characteristics Total
(N = 2433)
Urban Lima
(N = 891)
Urban Puno
(N = 357)
Semi-urban
Tumbes (N = 890)
Rural Puno
(N = 295)
Pa
Sex 0.660
Female 1248 (51.3) 471 (52.9) 182 (51.0) 444 (49.9) 151 (51.2)
Male 1184 (48.7) 420 (47.1) 175 (49.0) 446 (50.1) 143 (48.5)
Age (years) 0.481
36–44 434 (17.8) 156 (17.5) 59 (16.5) 165 (18.5) 54 (18.3)
45–54 655 (26.9) 250 (28.1) 103 (28.9) 230 (25.8) 72 (24.4)
55–64 664 (27.3) 256 (28.7) 94 (26.3) 226 (25.4) 88 (29.8)
C65 673 (27.7) 226 (25.4) 101 (28.3) 265 (29.8) 81 (27.5)
Educational level \0.001
Primary or less 1053 (43.3) 362 (40.6) 40 (11.2) 479 (53.8) 172 (58.3)
Secondary 849 (34.9) 371 (41.6) 93 (26.1) 282 (31.7) 103 (34.9)
Superior 529 (21.7) 157 (17.6) 224 (62.7) 128 (14.4) 20 (6.8)
Wealth index \0.001
Lowest tertile 678 (27.9) 111 (12.5) 75 (21.0) 285 (32.0) 207 (70.2)
Middle tertile 850 (34.9) 329 (36.9) 78 (21.8) 362 (40.7) 81 (27.5)
Highest tertile 905 (37.2) 451 (50.6) 204 (57.1) 243 (27.3) 7 (2.4)
Chronic conditions
Hypertension 573 (23.6) 184 (20.7) 45 (12.6) 317 (35.6) 27 (9.2) \0.001
Chronic bronchitis 309 (12.7) 87 (9.8) 72 (20.2) 42 (4.7) 108 (36.6) \0.001
Depressive mood 309 (12.7) 141 (15.8) 45 (12.6) 55 (6.2) 68 (23.1) \0.001
Type 2 diabetes 254 (10.4) 82 (9.2) 33 (9.2) 124 (13.9) 15 (5.1) \0.001
Heart disease 131 (5.4) 64 (7.2) 28 (7.8) 37 (4.2) 2 (0.7) \0.001
Stroke 20 (0.8) 13 (1.5) 2 (0.6) 4 (0.4) 1 (0.3) 0.069
Number of chronic conditions \0.001
0 1281 (52.7) 499 (56.0) 202 (56.6) 456 (51.2) 124 (42.0)
1 796 (32.7) 260 (29.2) 95 (26.6) 312 (35.1) 129 (43.7)
2 276 (11.3) 87 (9.8) 51 (14.3) 103 (11.6) 35 (11.9)
C3 80 (3.3) 45 (5.1) 9 (2.5) 19 (2.1) 7 (2.4)
EQ-visual analogue scorea 69.4 ± 16.1 71.9 ± 17.3 67.1 ± 16.5 70.7 ± 13.5 60.4 ± 15.6 \0.001
EQ-5D dimensions
Pain/discomfort 939 (38.6) 389 (43.7) 166 (46.5) 224 (25.2) 160 (54.2) \0.001
Mobility 427 (17.6) 186 (20.9) 51 (14.3) 113 (12.7) 77 (26.1) \0.001
Anxiety/depression 378 (15.5) 184 (20.7) 82 (23.0) 45 (5.1) 67 (22.7) \0.001
Usual activities 198 (8.1) 77 (8.6) 29 (8.1) 41 (4.6) 51 (17.3) \0.001
Self-care 64 (2.6) 26 (2.9) 7 (2.0) 11 (1.2) 20 (6.8) \0.001
a p values were calculated using v2 or ANOVA tests
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the gravity and the complications of T2D could also play a
role in subjective QOL.
Number of chronic conditions and EQ-VAS score
For each additional chronic condition, our participants
showed a 3.4-unit reduction in their EQ-VAS score. This
reduction is substantial, since data from a 5-year cohort
population study of elderly Italians found that one unit
decrease in EQ-VAS was associated to a 1% increase in
mortality and hospitalization rates [38]. As such,
strategies to improve QOL in persons with chronic
conditions are needed. Increasing healthcare access for
physician visits, incorporating disease self-management
skills [39], and designing individualized patient regimen
with consideration of treatment side effects [40] could
potentially decrease treatment burden and therefore
improve QOL.
Table 3 Association of number of chronic conditions and each specific chronic condition with EQ-VAS score, by study site
Exposures Total (N = 2433) Lima (N = 891) Urban Puno
(N = 357)
Semi-urban Tumbes
(N = 890)
Rural Puno
(N = 295)
LR test pa
b (95% CI) b (95% CI) b (95% CI) b (95% CI) b (95% CI)
Chronic conditions
Hypertension -0.4 (-1.9, 1.1) -3.2 (-6.1, -0.3) -2.2 (-7.7, 3.3) -1.6 (-3.5, 0.4) 2.1 (-3.3, 7.5) 0.66
Chronic
bronchitis
-5.7 (-7.6, -3.8) -1.8 (-5.4, 1.8) -4.2 (-7.8, -0.6) -4.3 (-9.2, 0.7) -3.5 (-7.4, 0.4) 0.59
Depressive mood -10.5 (-12.8,
-8.2)
-13.7 (-17.2,
-10.2)
-7.9 (-14.3,
-1.4)
-11.0 (-15.2,
-6.9)
-2.7 (-8.3, 2.9) <0.001
Type 2 diabetes -1.3 (-3.6, 0.9) -2.9 (-7.6, 1.8) 2.1 (-4.5, 8.7) -2.3 (-4.8, 0.2) -1.7 (-12.5,
9.2)
0.44
Number of chronic
conditions
-3.4 (-4.3, -2.5) -4.1 (-5.6, -2.6) -3.3 (-5.4, -1.3) -2.7 (-4.1, -1.4) -2.3 (-5.1, 0.4) 0.64
We used linear regression models with robust variances. All models were adjusted for sex, age, education status, and wealth index. Stroke and
heart disease were not evaluated due to the small number of cases
Significant associations (p\ 0.05) are bolded
a Likelihood-ratio test to assess the potential effect modifier of study site
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Table 4 Association of number of chronic conditions with EQ-5D dimensions, by study site
Outcomes Total
(N = 2433)
Lima (N = 891) Urban Puno
(N = 357)
Semi-urban Tumbes
(N = 890)
Rural Puno
(N = 295)
LR test pa
PR (95% CI) PR (95% CI) PR (95% CI) PR (95% CI) PR (95% CI)
Pain/discomfort 1.23 (1.17–1.30) 1.19 (1.11–1.28) 1.14 (1.02–1.27) 1.43 (1.29–1.60) 1.12 (0.99–1.26) 0.08
Mobility 1.38 (1.27–1.50) 1.40 (1.25–1.58) 1.41 (1.14–1.73) 1.25 (1.04–1.50) 1.50 (1.25–1.80) 0.67
Anxiety/depression 1.67 (1.53–1.81) 1.66 (1.48–1.85) 1.42 (1.20–1.69) 2.23 (1.71–2.92) 1.54 (1.26–1.89) 0.16
Usual activities 1.57 (1.38–1.78) 1.57 (1.29–1.93) 1.44 (1.10–1.88) 1.74 (1.33–2.27) 1.44 (1.15–1.81) 0.77
Self-care 1.98 (1.57–2.49) 1.70 (1.16–2.49) 2.81 (1.18–6.71) 3.61 (2.07–6.30) 1.80 (1.04–3.10) 0.36
All models were adjusted for sex, age, education status, and wealth index
a Likelihood-ratio test to assess the potential effect modification of study site
Qual Life Res
123
EQ-VAS score was 3.4 points lower for each additional
chronic condition. In comparison, a previous study in the
United Kingdom found that EQ-VAS score was 5.9 points
lower for each additional chronic condition [9]. This study
evaluated six chronic conditions: HTN, T2D, cerebrovas-
cular disease, ischemic heart disease, COPD, and asthma,
but it did not evaluated depressive mood, which had the
highest impact in QOL in our study. Thus, it is possible that
the EQ-VAS score per chronic condition would be even
lower in this UK study if depressive mood had been
included. Then, there could be a great difference between
this study and ours in terms of QOL affectation by chronic
conditions. This could be explained by the severity of the
United Kingdom subjects, who were registered with gen-
eral practitioners who probably see patients with more
advanced complications of their chronic diseases.
Number of chronic conditions and EQ-VAS score
per site
Average EQ-VAS score was higher in Lima and semi-
urban Tumbes, intermediate in urban Puno, and lower in
rural Puno. This linearly reflects the degree of urbanization,
with the exception of semi-urban Tumbes, with values
similar to urban Lima. It is possible that semi-urban
Tumbes dwellers have strong social or familiar support,
similar to those in rural areas as described elsewhere [41],
while at the same time having better healthcare access,
similar to urban areas. This could also explain the low
depressive mood prevalence in this semi-urban site.
Lower QOL values in the rural site could be due to less
education, poor economic status, and limited access to
health services; all increasing their risk of developing
severe health complications [14–16]. In addition, people
living in rural areas are more likely to be involved in
manual labor and may require more physical skills to
perform their usual activities; thus, the decrease of physical
capabilities in rural dwellers could have a greater impact
on subjective wellbeing than in urban dwellers. Such
regional observations would suggest that a higher number
of chronic diseases would more dramatically affect QOL in
rural than urban sites. However, our results show that EQ-
VAS scores per number of chronic conditions were similar
across studied sites.
This is probably because the average EQ-VAS score in
those without chronic conditions was higher in Lima than
in rural Puno (75 and 62 points, respectively). Due to the
subjective nature of the EQ-VAS assessment, the same
condition could cause a larger decrease in QOL in Lima
than in rural Puno [42]. If this is true, it would be incorrect
to compare linear regression coefficients with EQ-VAS;
therefore, future studies should evaluate this hypothesis
comparing EQ-VAS with other more objective QOL
questionnaires. Another potential explanation is that rural
dwellers may have a higher emotional resilience, which
could diminish the subjective effect of chronic conditions
on their QOL, as seen in the lower impact of depressive
mood on EQ-VAS in rural sites. This should be more
thoroughly studied to better understand what factors pre-
dict and define QOL for people living in rural versus urban
sites.
However, few studies have evaluated the differences of
social support, familial support, healthcare access, educa-
tion, economic status, and labor characteristics, across
Peruvian sites, and especially in sites with a heterogeneity
of urbanization degree patterns. Moreover, there is a pau-
city of information about the impact of these variables in
objective and subjective QOL. Understanding what levels
or profiles of urbanization are directly linked with be
deeply studied in order to understand QOL across different
sites warrants further evaluation.
Number of chronic conditions and EQ-5D
dimensions
The most prevalent EQ-5D dimension was pain and the
least prevalent was self-care, similar to previous studies
[9, 11, 43]. All dimensions but anxiety/depression had a
higher prevalence in the rural site, while the lowest
prevalence across all EQ-5D dimensions was observed in
semi-urban Tumbes. This could relate to the rural contex-
tual features and the Tumbes familiar/social support
described above.
Strength and limitations
This study compared the association of multiple and
specific chronic conditions and QOL within urban and rural
sites. Its results might help us to understand how health-
related QOL varies among intra-national sites.
Limitations of our study are as follows: (1) not all
chronic conditions with chief impact on QOL were inclu-
ded, such as cancer, chronic pain, and arthritis [10, 11], so
that the inclusion of these conditions could increase the
impact of number of chronic conditions on EQ-VAS. (2)
Some of our diagnostic criteria for chronic conditions are
not the current gold standard, such as blood pressure
measure in a single day for HTN, and the evaluation of a
single fasting blood glucose sample for T2D. In addition,
our chronic bronchitis diagnosis was based on symptoms
presented during the last 12 months while other studies
required symptom persistence for at least 2 years to con-
sider a diagnosis of chronic bronchitis [24]. These evalu-
ations could be over-estimating the prevalence of some
chronic conditions, although they could be more accurate
than the self-report used in similar previous studies
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[35–37]. (3) Diminished sample representativeness, espe-
cially in older and poor participants, could be underesti-
mating the association, since these subjects could have a
greater QOL decrease due to insufficient care of their
chronic conditions. (4) Low sample size, especially in rural
Puno, which could affect the extrapolation of our results to
this site.
Conclusion
Depressive mood, chronic bronchitis, and the number of
chronic conditions were related to lower EQ-VAS scores.
The associations between HTN, chronic bronchitis, T2D,
and number of chronic conditions with EQ-VAS score
were similar across sites with different levels of urban-
ization, while depressive mood had a larger impact on
EQ-VAS score for participants living in urban sites than
those living in rural sites. This suggests that urbanization
could influence the impact that some chronic conditions
have on health-related QOL, and warrants attention to
context when evaluating and comparing QOL across dif-
ferent sites.
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